Newsletter Signup
Where current and emerging technology trends meet.
TecTrendsInformation Sources, Inc.
  | About TecTrends | Email Signup | Contact Us
 Live Search:
Live Search | Articles | Companies | TecTerms | Products
  Loading TecTrends Live Search - please wait... 
View Noteworthy Articles      PRNewswire
 
Company

GeneMax Corp
1681 Chestnut St #400
Vancouver,  BC  V6J 4M6
Canada
Telephone: (604) 331-0400
Fax: (604) 331-0877
URL: http://www.genemax.com
Email: info@genemax.com

GeneMax Corporation, founded in 2000, is a biotechnology development firm. The company focuses on the use of cellular and molecular immunology technologies in the treatment of disease. Its products support the treatment of cancer, infectious diseases, and auto-immune disorders. They also are used in addressing transplant tissue rejection problems. GeneMax licenses technologies developed at the University of British Columbia. The firm is known for its TAP-1 Cancer Vaccine, patented in 2002, and its Immunomodulating Peptide Transfer Assay (IPTA) technologies. Ronald GeneMax is listed on the OTCBB exchange under the GMXX symbol. The company is a corporate affiliate of the Canadian Network for Vaccines and Immuno-therapeutics (CANVAC).

Org. Type: Corporation Equity Type: Public
Company Status: Active Date Founded: 2000
Symbol: OTCBB: GMXX

TecTerms:
 


Home About TecTrends About Us Contact Us Privacy Statement Terms and Conditions

TecTrends | P.O. Box 8120 | Berkeley CA 94707 | (510) 525-6220 | Email: tectrends@tectrends.com
© 2006 INFORMATION SOURCES INC | All rights reserved.